Eight Ways to Evaluate a Telehealth Vendor
A look at the questions you should be asking during the decision-making process of picking a telehealth vendor.
Adapting Neurological Care Amid COVID-19
In the wake of the COVID-19 pandemic, health care providers and patients have had to quickly adapt to new formats of care models to promote safety while retaining care standards.
Stroke Care Evolves During These Uncertain Times
Andrew Russman, DO, guest editor for NeurologyLive, provides insight on how stroke care has changed during the COVID-19 pandemic.
Verdiperstat Aims to Be First DMT for Multiple System Atrophy
Biohaven’s verdiperstat has entered a phase 3 trial for the treatment of multiple system atrophy, with a new drug application submission on the agenda for late 2021.
Targeting Bruton Tyrosine Kinase for Multiple Sclerosis Treatment
An in-depth look into the expanding landscape of multiple sclerosis treatments that target bruton tyrosine kinase.
Managing Narcolepsy and Excessive Daytime Sleepiness
In this Peer Exchange, sleep experts provide insight into the latest narcolepsy treatments and areas that require further research.
Treating Medication Overuse Headache: Opportunities for Improvement
A whole-patient approach to management, coupled with new, more targeted treatments, may help reduce the incidence of medication overuse headache.
The Road to Accessible Biomarkers for Alzheimer Disease
Biomarkers in the cerebrospinal fluid and blood could hold the key to early diagnosis of Alzheimer disease.
Keeping Treatment Response "On" in Parkinson Disease
New drug classes and formulations may help hold off breakthrough activity as the research community works to optimize levodopa delivery and absorption.
Improving Stroke Systems of Care for Better Outcomes
The “time is brain” mantra continues to drive innovation in a specialty that will not settle for mediocrity.
2 Clarke Drive Cranbury, NJ 08512